CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 652,352	$ 501,461
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	218,022	211,298
Deferred income tax expense (benefit)	(19,493)	8,952
Stock-based compensation	14,185	6,811
Loan cost amortization	2,491	2,573
Loss on property disposals	1,990	2,715
Loss (gain) on early extinguishment of debt recognized as a component of interest expense	1,419	(11,159)
Accretion of discount related to Senior Notes	1,211	1,289
Asset impairment	846	13,412
Gain on equity-method investments	(3)	(3)
Changes in operating assets and liabilities:
Trade accounts and other receivables	(74,961)	62,350
Inventories	(105,692)	146,189
Prepaid expenses and other current assets	(17,434)	(43,532)
Accounts payable, accrued expenses and other current liabilities	(34,570)	14,290
Income taxes	8,048	88,631
Long-term pension and other postretirement obligations	(1,469)	3,652
Other operating assets and liabilities	(24,839)	(19,273)
Cash provided by operating activities	622,103	989,656
Cash flows from investing activities:
Acquisitions of property, plant and equipment	(259,283)	(213,247)
Proceeds from property disposals	2,912	4,551
Cash used in investing activities	(256,371)	(208,696)
Cash flows from financing activities:
Payments for dividend	(1,495,497)	0
Payments on revolving line of credit, long-term borrowings and finance lease obligations	(90,654)	(150,895)
Payment on early extinguishment of debt	(2,120)	(200)
Proceeds from contribution of capital under Tax Sharing Agreement between JBS USA Holdings and Pilgrim’s Pride Corporation	0	1,425
Payments of capitalized loan costs	0	(16)
Cash used in financing activities	(1,588,271)	(149,686)
Effect of exchange rate changes on cash and cash equivalents	37,700	(28,371)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(1,184,839)	602,903
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	2,043,158	731,223
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period	$ 858,319	$ 1,334,126